Cigarette smoking during pregnancy and preeclampsia risk: A systematic review and meta-analysis of prospective studies

Oncotarget

Volumn 6, Issue 41, 2015, Pages 43667-43678

  Wei, Jun ^a   Liu, Cai Xia ^a   Gong, Ting Ting ^a   Wu, Qi Jun ^a   Wu, Lang ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b MAYO CLINIC   (United States)

Author keywords

Cigarette smoking; Meta analysis; Preeclampsia; Risk factor

Indexed keywords

ARTICLE; BODY MASS; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; INFORMATION RETRIEVAL; MATERNAL AGE; MEDLINE; META ANALYSIS (TOPIC); PARITY; PREECLAMPSIA; PREGNANCY; PROSPECTIVE STUDY; RISK FACTOR; SAMPLE SIZE; SMOKING; SYSTEMATIC REVIEW; WEB OF SCIENCE; ADVERSE EFFECTS; FEMALE; INCIDENCE; META ANALYSIS; PRE-ECLAMPSIA; RISK;

FEMALE; HUMANS; INCIDENCE; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK; SMOKING;

EID: 84952917116     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6190     Document Type: Article

References (63)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010; 376:631-644.
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365:785-799.
3. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001; 357:53-56.
4. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22:143-148.
5. Roberts JM, Hubel CA. The two stage model of preeclampsia:variations on the theme. Placenta. 2009; 30 Suppl A:S32-S37.
6. Arngrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol. 1990; 97:762-769.
7. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol. 1998; 16:93-104.
8. Salihu HM, Wilson RE. Epidemiology of prenatal smoking and perinatal outcomes. Early Hum Dev. 2007; 83:713-720.
9. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350:672-683.
10. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006; 355:992-1005.
11. Ylikorkala O, Viinikka L, Lehtovirta P. Effect of nicotine on fetal prostacyclin and thromboxane in humans. Obstet Gynecol. 1985; 66:102-105.
12. Marcoux S, Brisson J, Fabia J. The effect of cigarette smoking on the risk of preeclampsia and gestational hypertension. Am J Epidemiol. 1989; 130:950-957.
13. Madazli R, Benian A, Aydin S, Uzun H, Tolun N. The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia. J Obstet Gynaecol. 2002; 22:477-480.
14. Bainbridge SA, Sidle EH, Smith GN. Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses. 2005; 64:17-27.
15. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease. Am J Obstet Gynecol. 2013; 209:541-544.
16. Perni UC, Wikstrom AK, Cnattingius S, Villamor E. Interpregnancy change in smoking habits and risk of preeclampsia: a population-based study. Am J Hypertens. 2012; 25:372-378.
17. Stone CD, Diallo O, Shyken J, Leet T. The combined effect of maternal smoking and obesity on the risk of preeclampsia. J Perinat Med. 2007; 35:28-31.
18. Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol. 2005; 192:1856-1862, 1862-1863.
19. Basso O, Weinberg CR, Baird DD, Wilcox AJ, Olsen J. Subfecundity as a correlate of preeclampsia: a study within the Danish National Birth Cohort. Am J Epidemiol. 2003; 157:195-202.
20. Mortensen JT, Thulstrup AM, Larsen H, Moller M, Sorensen HT. Smoking, sex of the offspring, and risk of placental abruption, placenta previa, and preeclampsia: a population-based cohort study. Acta Obstet Gynecol Scand. 2001; 80:894-898.
21. Newman MG, Lindsay MK, Graves W. Cigarette smoking and pre-eclampsia: their association and effects on clinical outcomes. J Matern Fetal Med. 2001; 10:166-170.
22. Martin CL, Hall MH, Campbell DM. The effect of smoking on pre-eclampsia in twin pregnancy. BJOG. 2000; 107:745-749.
23. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. BJOG. 2000; 107:1410-1416.
24. Xiong X, Wang FL, Davidge ST, Demianczuk NN, Mayes DC, Olson DM, Saunders LD. Maternal smoking and preeclampsia. J Reprod Med. 2000; 45:727-732.
25. Lindqvist PG, Marsal K. Moderate smoking during pregnancy is associated with a reduced risk of preeclampsia. Acta Obstet Gynecol Scand. 1999; 78:693-697.
26. Zhang J, Klebanoff MA, Levine RJ, Puri M, Moyer P. The puzzling association between smoking and hypertension during pregnancy. Am J Obstet Gynecol. 1999; 181:1407-1413.
27. Cnattingius S, Mills JL, Yuen J, Eriksson O, Salonen H. The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am J Obstet Gynecol. 1997; 177:156-161.
28. Coonrod DV, Hickok DE, Zhu K, Easterling TR, Daling JR. Risk factors for preeclampsia in twin pregnancies: a population-based cohort study. Obstet Gynecol. 1995; 85:645-650.
29. Ioka A, Tsukuma H, Nakamuro K. Lifestyles and preeclampsia with special attention to cigarette smoking. J Epidemiol. 2003; 13:90-95.
30. England LJ, Levine RJ, Qian C, Morris CD, Sibai BM, Catalano PM, Curet LB, Klebanoff MA. Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2002; 186:1035-1040.
31. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study. Obstet Gynecol. 1998; 92:174-178.
32. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, Goldenberg RL, Joffe G. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997; 177:1003-1010.
33. England L, Zhang J. Smoking and risk of preeclampsia: a systematic review. Front Biosci. 2007; 12:2471-2483.
34. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol. 1999; 181:1026-1035.
35. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998; 280:1690-1691.
36. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007; 115:1789-1797.
37. Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens. 2008; 21:943-947.
38. Salafia C, Shiverick K. Cigarette smoking and pregnancy II: vascular effects. Placenta. 1999; 20:273-279.
39. Shah NR, Bracken MB. A systematic review and metaanalysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol. 2000; 182:465-472.
40. England LJ, Grauman A, Qian C, Wilkins DG, Schisterman EF, Yu KF, Levine RJ. Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine Tob Res. 2007; 9:1005-1013.
41. George L, Granath F, Johansson AL, Cnattingius S. Selfreported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand. 2006; 85:1331-1337.
42. Gong TT, Wu QJ, Wang YL, Ma XX. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies. Int J Cancer. 2015; 137:1967-1978.
43. Jiao YS, Gong TT, Wang YL, Wu QJ. Comorbidity and survival among women with ovarian cancer: evidence from prospective studies. Sci Rep. 2015; 5:11720.
44. Gong TT, Wang YL, Ma XX. Age at menarche and endometrial cancer risk: a dose-response meta-analysis of prospective studies. Sci Rep. 2015; 5:14051.
45. Wu QJ, Li YY, Tu C, Zhu J, Qian KQ, Feng TB, Li C, Wu L, Ma XX. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies. Sci Rep. 2015; 5:14243.
46. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283:2008-2012.
47. Luan NN, Wu L, Gong TT, Wang YL, Lin B, Wu QJ. Nonlinear reduction in risk for colorectal cancer by oral contraceptive use: a meta-analysis of epidemiological studies. Cancer Causes Control. 2015; 26:65-78.
48. Luan NN, Wu QJ, Gong TT, Vogtmann E, Wang YL, Lin B. Breastfeeding and ovarian cancer risk: a metaanalysis of epidemiologic studies. Am J Clin Nutr. 2013; 98:1020-1031.
49. Wells, G. A., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. (Date of access: 12/September/2015).
50. Gong TT, Wu QJ, Vogtmann E, Lin B, Wang YL. Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies. Int J Cancer. 2013; 132: 2894-2900.
51. Wu QJ, Yang Y, Vogtmann E, Wang J, Han LH, Li HL, Xiang YB. Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Ann Oncol. 2013; 24:1079-1087.
52. Wu QJ, Yang Y, Wang J, Han LH, Xiang YB. Cruciferous vegetable consumption and gastric cancer risk: a metaanalysis of epidemiological studies. Cancer Sci. 2013; 104:1067-1073.
53. Wu QJ, Xie L, Zheng W, Vogtmann E, Li HL, Yang G, Ji BT, Gao YT, Shu XO, Xiang YB. Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta-analysis. Ann Oncol. 2013; 24:1918-1924.
54. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol. 1994; 140:290-296.
55. Greenland S, O'Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics. 2001; 2:463-471.
56. Greenland, S, O' Rourke K. Meta-analysis. In: Modern Epidemiology, 3rd edn, (eds Rothman, K.J. et al.) 652-682. (Lippincott Williams & Wilkins, 2008).
57. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21:1539-1558.
58. Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med. 2008; 27:954-970.
59. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327:557-560.
60. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177-188.
61. Yang Y, Zhao LG, Wu QJ, Ma X, Xiang YB. Association between dietary fiber and lower risk of all-cause mortality: a meta-analysis of cohort studies. Am J Epidemiol. 2015; 181:83-91.
62. Egger M, Davey SG, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997; 315:629-634.
63. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088-1101.